Phantosmias and Parkinson disease

Archives of Neurology

Volumn 65, Issue 9, 2008, Pages 1237-1239

  Landis, Basile N ^a   Burkhard, Pierre R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARBIDOPA; ENTACAPONE; IODINE 123; LEVODOPA; PRAMIPEXOLE; RASAGILINE;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORPUS STRIATUM; DRUG UPTAKE; ELECTROENCEPHALOGRAPHY; FEMALE; HAND TREMOR; HUMAN; HYPOSMIA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTOMETRY; OLFACTORY BULB; OLFACTORY HALLUCINATION; OTORHINOLARYNGOLOGY; PARKINSON DISEASE; PARKINSONISM; PERCEPTIVE THRESHOLD; PHANTOSMIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RIGIDITY; SMELLING DISORDER; TEMPORAL LOBE;

FEMALE; HALLUCINATIONS; HUMANS; MIDDLE AGED; OLFACTION DISORDERS; PARKINSON DISEASE;

EID: 51649121144     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.9.1237     Document Type: Article

References (21)

1. Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J Chronic Dis. 1975;28(9):493-497.
2. Doty RL, Deems D, Steller S. Olfactory dysfunction in Parkinson's disease: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38(8):1237-1244.
3. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters EC, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 2004;56(2):173-181.
4. Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord. 2007;22(6):839-842.
5. Katzenschlager R, Lees AJ. Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr Opin Neurol. 2004;17(4):417-423.
6. Ondo WG, Lai D. Olfaction testing in patients with tremor-dominant Parkinson's disease: is this a distinct condition? Mov Disord. 2005;20(4):471-475.
7. Marras C, Goldman S, Smith A. Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Disord. 2005;20(6):687-693.
8. Khan NL, Jain S, Lynch JM, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain. 2005;128(pt 12):2786-2796.
9. Khan NL, Katzenschlager R, Watt H, et al. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology. 2004;62(7):1224-1226.
10. Kobal G, Klimek L, Wolfensberger M, et al. Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol. 2000;257(4):205-211.
11. Leopold D. Distortion of olfactory perception: diagnosis and treatment. Chem Senses. 2002;27(7):611-615.
12. Frasnelli J, Landis BN, Heilmann S, et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2004;261(7):411-415.
13. Sandyk R. Olfactory hallucinations in Parkinson's disease. S Afr Med J. 1981;60(25):950.
14. Reden J, Maroldt H, Fritz A, Zahnert T, Hummel T. A study on the prognostic significance of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2007;264(2):139-144.
15. Tousi B, Frankel M. Olfactory and visual hallucinations in Parkinson's disease. Parkinsonism Relat Disord. 2004;10(4):253-254.
16. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197-211.
17. Mueller A, Abolmaali ND, Hakimi AT, et al. Olfactory bulb volumes in patients with idiopathic Parkinson's disease: a pilot study. J Neural Transm. 2005;112(10):1363-1370.
18. Huisman E, Uylings HBM, Hoogland PV. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord. 2004;19(6):687-692.
19. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord. 1995;10(3):283-287.
20. Hubbard PS, Esiri MM, Reading M, McShane R, Nagy Z. Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat. 2007;211(1):117-124.
21. Westermann B, Wattendorf E, Schwerdtfeger U, et al. Functional imaging of the cerebral olfactory system in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008;79(1):19-24.